Covidien (Mansfield, Massachusetts) has enrolled the first patients in the ILLUMENATE pivotal and ILLUMENATE PK (Pharmacokinetics) trials. Both are components of the global ILLUMENATE clinical trial program, a series of studies on the safety and effectiveness of Covidien's Stellarex drug-coated angioplasty balloon for the treatment of patients with peripheral arterial disease (PAD). Read More
